Interpharm Holdings, Inc.
IPAH
$0.00
$0.000.00%
OTC PK
| 12/31/2007 | 09/30/2007 | ||||
|---|---|---|---|---|---|
| Revenue | -8.47% | 15.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -8.47% | 15.10% | |||
| Cost of Revenue | -16.19% | 26.94% | |||
| Gross Profit | 110.87% | -52.87% | |||
| SG&A Expenses | -12.43% | 2.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.58% | 4.83% | |||
| Operating Income | 36.03% | 16.60% | |||
| Income Before Tax | 28.64% | 12.29% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -58.02% | 29.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -58.02% | 29.07% | |||
| EBIT | 36.03% | 16.60% | |||
| EBITDA | 42.42% | 20.76% | |||
| EPS Basic | -104.20% | 32.23% | |||
| Normalized Basic EPS | 29.19% | 11.73% | |||
| EPS Diluted | -104.20% | 33.24% | |||
| Normalized Diluted EPS | 29.19% | 11.73% | |||
| Average Basic Shares Outstanding | 0.82% | 0.58% | |||
| Average Diluted Shares Outstanding | 0.82% | 0.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||